Bristol-Myers Squibb

Bristol Myers Squibb

Biologics Plant

Site selection and incentives consultation services were needed for a highly competitive nationwide search for a $750 million, large-scale multi-product bulk biologics campus in Devens, MA. The facility (the largest capital investment in BMS history) supports the production of ORENCIA®, the company's biologic therapy for rheumatoid arthritis. The project, which created 550 jobs, benefitted from an incentives package worth more than $107 million (NPV).